Tags

Type your tag names separated by a space and hit enter

Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines.
Am J Obstet Gynecol. 2018 08; 219(2):129-146.e2.AJ

Abstract

OBJECTIVE

We aimed to systematically review the literature on apical pelvic organ prolapse surgery with uterine preservation compared with prolapse surgeries including hysterectomy and provide evidence-based guidelines.

DATA SOURCES

The sources for our data were MEDLINE, Cochrane, and clinicaltrials.gov databases from inception to January 2017.

STUDY ELIGIBILITY CRITERIA

We accepted randomized and nonrandomized studies of uterine-preserving prolapse surgeries compared with those involving hysterectomy.

STUDY APPRAISAL AND SYNTHESIS METHODS

Studies were extracted for participant information, intervention, comparator, efficacy outcomes, and adverse events, and they were individually and collectively assessed for methodological quality. If 3 or more studies compared the same surgeries and reported the same outcome, a meta-analysis was performed.

RESULTS

We screened 4467 abstracts and identified 94 eligible studies, 53 comparing uterine preservation to hysterectomy in prolapse surgery. Evidence was of moderate quality overall. Compared with hysterectomy plus mesh sacrocolpopexy, uterine preservation with sacrohysteropexy reduces mesh exposure, operative time, blood loss, and surgical cost without differences in prolapse recurrence. Compared with vaginal hysterectomy with uterosacral suspension, uterine preservation in the form of laparoscopic sacrohysteropexy improves the C point and vaginal length on the pelvic organ prolapse quantification exam, estimated blood loss, postoperative pain and functioning, and hospital stay, but open abdominal sacrohysteropexy worsens bothersome urinary symptoms, operative time, and quality of life. Transvaginal mesh hysteropexy (vs with hysterectomy) decreases mesh exposure, reoperation for mesh exposure, postoperative bleeding, and estimated blood loss and improves posterior pelvic organ prolapse quantification measurement. Transvaginal uterosacral or sacrospinous hysteropexy or the Manchester procedure compared with vaginal hysterectomy with native tissue suspension both showed improved operative time and estimated blood loss and no worsening of prolapse outcomes with uterine preservation. However, there is a significant lack of data on prolapse outcomes >3 years after surgery, the role of uterine preservation in obliterative procedures, and longer-term risk of uterine pathology after uterine preservation.

CONCLUSION

Uterine-preserving prolapse surgeries improve operating time, blood loss, and risk of mesh exposure compared with similar surgical routes with concomitant hysterectomy and do not significantly change short-term prolapse outcomes. Surgeons may offer uterine preservation as an option to appropriate women who desire this choice during apical prolapse repair.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, University of Louisville, Louisville, KY. Electronic address: kate.meriwether@louisville.edu.Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, TX.Department of Obstetrics and Gynecology, New York University, New York, NY.Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada.Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, RI.The Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, PA.Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY.International Medical Response, New York, NY.Department of Obstetrics and Gynecology, University of Florida Health, Jacksonville, FL.Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC.TriHealth, Cincinnati, OH.Department of Obstetrics and Gynecology, University of Texas Southwestern, Dallas, TX.

Pub Type(s)

Comparative Study
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review

Language

eng

PubMed ID

29353031

Citation

Meriwether, Kate V., et al. "Uterine Preservation Vs Hysterectomy in Pelvic Organ Prolapse Surgery: a Systematic Review With Meta-analysis and Clinical Practice Guidelines." American Journal of Obstetrics and Gynecology, vol. 219, no. 2, 2018, pp. 129-146.e2.
Meriwether KV, Antosh DD, Olivera CK, et al. Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. Am J Obstet Gynecol. 2018;219(2):129-146.e2.
Meriwether, K. V., Antosh, D. D., Olivera, C. K., Kim-Fine, S., Balk, E. M., Murphy, M., Grimes, C. L., Sleemi, A., Singh, R., Dieter, A. A., Crisp, C. C., & Rahn, D. D. (2018). Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. American Journal of Obstetrics and Gynecology, 219(2), 129-e2. https://doi.org/10.1016/j.ajog.2018.01.018
Meriwether KV, et al. Uterine Preservation Vs Hysterectomy in Pelvic Organ Prolapse Surgery: a Systematic Review With Meta-analysis and Clinical Practice Guidelines. Am J Obstet Gynecol. 2018;219(2):129-146.e2. PubMed PMID: 29353031.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. AU - Meriwether,Kate V, AU - Antosh,Danielle D, AU - Olivera,Cedric K, AU - Kim-Fine,Shunaha, AU - Balk,Ethan M, AU - Murphy,Miles, AU - Grimes,Cara L, AU - Sleemi,Ambereen, AU - Singh,Ruchira, AU - Dieter,Alexis A, AU - Crisp,Catrina C, AU - Rahn,David D, Y1 - 2018/01/17/ PY - 2017/11/10/received PY - 2018/01/03/revised PY - 2018/01/10/accepted PY - 2018/1/22/pubmed PY - 2019/7/4/medline PY - 2018/1/22/entrez KW - hysteropexy KW - pelvic organ prolapse KW - surgery KW - transvaginal mesh KW - uterine preservation SP - 129 EP - 146.e2 JF - American journal of obstetrics and gynecology JO - Am J Obstet Gynecol VL - 219 IS - 2 N2 - OBJECTIVE: We aimed to systematically review the literature on apical pelvic organ prolapse surgery with uterine preservation compared with prolapse surgeries including hysterectomy and provide evidence-based guidelines. DATA SOURCES: The sources for our data were MEDLINE, Cochrane, and clinicaltrials.gov databases from inception to January 2017. STUDY ELIGIBILITY CRITERIA: We accepted randomized and nonrandomized studies of uterine-preserving prolapse surgeries compared with those involving hysterectomy. STUDY APPRAISAL AND SYNTHESIS METHODS: Studies were extracted for participant information, intervention, comparator, efficacy outcomes, and adverse events, and they were individually and collectively assessed for methodological quality. If 3 or more studies compared the same surgeries and reported the same outcome, a meta-analysis was performed. RESULTS: We screened 4467 abstracts and identified 94 eligible studies, 53 comparing uterine preservation to hysterectomy in prolapse surgery. Evidence was of moderate quality overall. Compared with hysterectomy plus mesh sacrocolpopexy, uterine preservation with sacrohysteropexy reduces mesh exposure, operative time, blood loss, and surgical cost without differences in prolapse recurrence. Compared with vaginal hysterectomy with uterosacral suspension, uterine preservation in the form of laparoscopic sacrohysteropexy improves the C point and vaginal length on the pelvic organ prolapse quantification exam, estimated blood loss, postoperative pain and functioning, and hospital stay, but open abdominal sacrohysteropexy worsens bothersome urinary symptoms, operative time, and quality of life. Transvaginal mesh hysteropexy (vs with hysterectomy) decreases mesh exposure, reoperation for mesh exposure, postoperative bleeding, and estimated blood loss and improves posterior pelvic organ prolapse quantification measurement. Transvaginal uterosacral or sacrospinous hysteropexy or the Manchester procedure compared with vaginal hysterectomy with native tissue suspension both showed improved operative time and estimated blood loss and no worsening of prolapse outcomes with uterine preservation. However, there is a significant lack of data on prolapse outcomes >3 years after surgery, the role of uterine preservation in obliterative procedures, and longer-term risk of uterine pathology after uterine preservation. CONCLUSION: Uterine-preserving prolapse surgeries improve operating time, blood loss, and risk of mesh exposure compared with similar surgical routes with concomitant hysterectomy and do not significantly change short-term prolapse outcomes. Surgeons may offer uterine preservation as an option to appropriate women who desire this choice during apical prolapse repair. SN - 1097-6868 UR - https://www.unboundmedicine.com/medline/citation/29353031/Uterine_preservation_vs_hysterectomy_in_pelvic_organ_prolapse_surgery:_a_systematic_review_with_meta_analysis_and_clinical_practice_guidelines_ DB - PRIME DP - Unbound Medicine ER -